Johnson & Johnson (JNJ) is a publicly traded Healthcare sector company. As of October 1, 2026, JNJ trades at $265.03 with a market cap of $644.82B and a P/E ratio of 30.45. JNJ moved -0.93% today. Year to date, JNJ is +27.68%; over the trailing twelve months it is +42.78%. Its 52-week range spans $141.50 to $281.07. Analyst consensus is strong buy with an average price target of $286.61. Rallies surfaces JNJ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for JNJ combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $265.03 |
| Market Cap | $644.82B |
| P/E Ratio | 30.45 |
| EPS | $8.73 |
| Dividend Yield | 1.34% |
| 52-Week High | $281.07 |
| 52-Week Low | $141.50 |
| Volume | 3.45M |
| Avg Volume | 0 |
| Revenue (TTM) | $97.93B |
| Net Income | $21.04B |
| Gross Margin | 67.91% |
18 analysts cover JNJ: 0 strong buy, 14 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $286.61.